STOCK TITAN

BioScience Health Innovations (BHICD) Debt by Year

BHICD OTC

BioScience Health Innovations Inc held $662K in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters BioScience Health Innovations Inc has filed alongside them.

FY2025 annual
Long-Term Debt N/A
Cash & Equivalents $662K
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

BHICD Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY23FY22FY21FY20
Long-Term DebtN/AN/AN/AN/AN/AN/A
Cash & Equivalents$662K-0.1%$663K+3343.8%$19K+66.3%$12K+468.5%$2K-90.1%$21K

BHICD Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'25Q1'2510-QQ4'2410-KQ3'2410-QQ2'24Q1'24Q4'23Q3'23Q2'23
Long-Term DebtN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$1.1M+11.3%$662K-0.1%$1.1M+241.9%$1.3M+802.9%$1.0M+1006.5%$663K+3343.8%$333K+693.6%$144K+374.7%$93K+882.0%$19K+66.3%$42K+456.8%$30K+268.5%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More BioScience Health Innovations Inc financials

Frequently Asked Questions

BioScience Health Innovations Inc held $662K in cash and equivalents at the end of fiscal year 2025, and no long-term debt figure is on record for that period.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what BioScience Health Innovations Inc (BHICD) reported on that line in every period on record.